Ro KhannaSell
QGEN Common Stock · Transaction Jan 13, 2022 · Filed May 6, 2022 · Amount pending receipt enrichment
NEW YORK STOCK EXCHANGE, INC. · QGEN
+1.37% · +$0.5700 · Vol 3.8M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Qiagen NV
Life Sciences Tools & Services
$42.30
Veridion Score
BETAHIGH CONF · 6/6 factorsSat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET · QGEN
MethodologyQGEN
Qiagen NV
Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
70/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is QGEN moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Qiagen NV
Life Sciences Tools & ServicesListed since
1996
Employees
6K
Country
NL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$42.51
Day high
$42.55
Day low
$41.96
Previous close
$41.73
52W high
$55.66
-24.00% from high
52W low
$32.63
42% of range
Market cap
$8.7B
P/E
21.68×
EPS
$1.89
Beta
0.66
Shares out
206.3M
Volume
3.8M
1.31× rel vol
Avg volume
2.9M
VWAP
$42.29
Price history computed in-house
1W
+2.17%
1M
+0.74%
3M
+28.03%
1Y
-11.95%
YTD
-5.94%
SMA 50 $39.34 · above
SMA 200 $42.98 · below
52W position 42%
QGEN overview
Related filings and maps
Public disclosures
Congress activity in QGEN
Official filing ↗
Ro KhannaSell
QGEN Common Stock · Transaction Apr 7, 2020 · Filed May 13, 2020 · Amount pending receipt enrichment
Donna ShalalaSell
QGEN Common Stock · Transaction Jan 23, 2019 · Filed Apr 27, 2020 · Amount pending receipt enrichment
Donna ShalalaSell
QGEN Common Stock · Transaction Jan 9, 2019 · Filed Apr 27, 2020 · Amount pending receipt enrichment
QGEN Common Stock · Transaction Feb 28, 2017 · Filed Mar 7, 2017 · Amount pending receipt enrichment
Federal contracts
QGEN contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for QGEN in this window.
Lobbying spend
QGEN lobbying filings, year to date.
Registered lobbying filings matched to Qiagen NV.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for QGEN in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for QGEN.
Options
Sovereign unlock shows live options positioning for QGEN.